返回 Agenda
Session Chair(s)
Darryl L'Heureux, PHD, MPHARM, MSC
Director, Clinical Science, Medical Writing, and Publications
Ambrx, Inc, United States
Learning Objective : -Explain the design of PRO assessment tools and appropriate selection and use of such tools -Discuss advantages and disadvantages of working collaboratively within a pre-competitive consortium to develop and qualify PRO instruments for use in clinical trials where PRO endpoints are used to support product labeling claims - Describe why electronic capture of PRO endpoint data in clinical trials is receiving increasing attention
Speaker(s)
Faculty
Darryl L'Heureux, PHD, MPHARM, MSC
Ambrx, Inc, United States
Director, Clinical Science, Medical Writing, and Publications
Faculty
Stephen Joel Coons, PHD
Critical Path Institute, United States
Senior Advisor
Faculty
J. Jason Lundy, PHD
Outcometrix, United States
Principal